IS5919A - New macrolide antibiotics - Google Patents

New macrolide antibiotics

Info

Publication number: IS5919A
Authority: IS; Iceland
Prior art keywords: macrolide antibiotics; new macrolide; new; antibiotics; macrolide
Prior art date: 1998-11-03

Application number

IS5919A

Other languages

Icelandic (is)

Inventor

Kaneko Takushi

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-03

Filing date

2001-04-17

Publication date

2001-04-17

2001-04-17 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2001-04-17 Publication of IS5919A publication Critical patent/IS5919A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

IS5919A 1998-11-03 2001-04-17 New macrolide antibiotics IS5919A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10683698P	1998-11-03	1998-11-03
PCT/IB1999/001701 WO2000026224A2 (en)	1998-11-03	1999-10-18	Novel macrolide antibiotics

Publications (1)

Publication Number	Publication Date
IS5919A true IS5919A (en)	2001-04-17

Family

ID=22313524

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5919A IS5919A (en)	1998-11-03	2001-04-17	New macrolide antibiotics

Country Status (34)

Country	Link
US (3)	US20020040007A1 (en)
EP (1)	EP1124837A2 (en)
JP (1)	JP4043191B2 (en)
KR (1)	KR20010083944A (en)
CN (1)	CN1376160A (en)
AP (1)	AP2001002131A0 (en)
AU (1)	AU5995299A (en)
BG (1)	BG105543A (en)
BR (1)	BR9914998A (en)
CA (1)	CA2349338C (en)
CO (1)	CO5140110A1 (en)
CZ (1)	CZ20011512A3 (en)
EA (1)	EA200100396A1 (en)
EE (1)	EE200100245A (en)
GT (1)	GT199900192A (en)
HK (1)	HK1049010A1 (en)
HR (1)	HRP20010306A2 (en)
HU (1)	HUP0104192A3 (en)
ID (1)	ID28286A (en)
IL (1)	IL142628A0 (en)
IS (1)	IS5919A (en)
MA (1)	MA26703A1 (en)
NO (1)	NO20012155L (en)
OA (1)	OA11670A (en)
PA (1)	PA8485101A1 (en)
PE (1)	PE20001289A1 (en)
PL (1)	PL348114A1 (en)
SK (1)	SK5812001A3 (en)
SV (1)	SV1999000188A (en)
TN (1)	TNSN99205A1 (en)
TR (4)	TR200200435T2 (en)
UY (1)	UY25780A1 (en)
WO (1)	WO2000026224A2 (en)
ZA (1)	ZA200103289B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AP9801420A0 (en) *	1998-01-02	1998-12-31	Pfizer Prod Inc	Novel macrolides.
EE200100245A (en)	1998-11-03	2002-10-15	Pfizer Products Inc.	New macrolide antibiotics
ID30233A (en)	1999-01-27	2001-11-15	Pfizer Prod Inc	ANTIBIOTICS OF TETOLIDA
US6514944B2 (en)	1999-04-16	2003-02-04	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6590083B1 (en)	1999-04-16	2003-07-08	Ortho-Mcneil Pharmaceutical, Inc.	Ketolide antibacterials
WO2000062783A2 (en)	1999-04-16	2000-10-26	Ortho-Mcneil Pharmaceutical, Inc.	Ketolide antibacterials
AU773678B2 (en)	1999-04-16	2004-06-03	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6939861B2 (en)	1999-04-16	2005-09-06	Kosan Biosciences, Inc.	Amido macrolides
US6451768B1 (en)	1999-04-16	2002-09-17	Kosan Biosciences, Inc.	Macrolide antiinfective agents
EP1180110A1 (en)	1999-05-24	2002-02-20	Pfizer Products Inc.	13-methyl-erythromycin derivatives
EP1114826A3 (en) *	1999-12-29	2001-10-31	Pfizer Products Inc.	Novel antibacterial and prokinetic macrolides
EP1146051A3 (en) *	2000-04-10	2001-10-31	Pfizer Products Inc.	Erythromycin A derivatives
PT1167376E (en)	2000-06-30	2004-09-30	Pfizer Prod Inc	MACROLIDOS ANTIBIOTICS
BRPI0513903A (en) *	2004-07-28	2008-05-20	Ranbaxy Lab Ltd	ketolide derivatives useful as antimicrobial agents, their preparation processes and pharmaceutical compositions comprising the same
EP1807439A2 (en) *	2004-10-25	2007-07-18	Ranbaxy Laboratories Limited	Ketolide derivatives as antibacterial agents
PL1836211T3 (en)	2004-12-21	2010-07-30	Pfizer Prod Inc	Macrolides
US20090005325A1 (en) *	2005-11-23	2009-01-01	Biswajit Bas	Ketolide Derivatives as Antibacterial Agents
WO2007060618A2 (en) *	2005-11-23	2007-05-31	Ranbaxy Laboratories Limited	Macrolides derivatives as antibacterial agents
US7801502B2 (en) *	2006-12-18	2010-09-21	Aai Corporation	Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
US8409628B2 (en)	2010-02-04	2013-04-02	Penguin IP Holdings, Inc.	Methods and compositions for oxygenation of skin to treat skin disorders
WO2011123619A2 (en)	2010-03-31	2011-10-06	Penguin Ip Holdings Inc.	Permeable mixtures, methods and compositions for the skin
RU2666605C2 (en) *	2013-05-01	2018-09-11	Неокули Пти Лтд	Methods of treating bacterial infections
RU2537143C1 (en) *	2013-11-08	2014-12-27	Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства РАСХН	Preparation for treatment and prevention of mastitis in cows
WO2018080072A2 (en) *	2016-10-27	2018-05-03	한국생명공학연구원	Novel macrolide-based compound, method for producing same, and pharmaceutical composition for preventing or treating malaria and containing same as active ingredient

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI8110592A8 (en) *	1981-03-06	1996-06-30	Pliva Pharm & Chem Works	Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) *	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
IL114589A (en) *	1990-11-21	1999-12-22	Roussel Uclaf	Intermediates for the preparation of erythromycin derivatives
US5527780A (en)	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2697524B1 (en) *	1992-11-05	1994-12-23	Roussel Uclaf	New erythromycin derivatives, their preparation process and their use as drugs.
US5332807A (en)	1993-04-14	1994-07-26	Merck & Co., Inc.	Process of producing 8A- and 9A-azalide antibiotics
FR2702480B1 (en) *	1993-03-09	1995-04-28	Roussel Uclaf	New erythromycin derivatives, their preparation process and their use as drugs.
HRP931480B1 (en)	1993-12-08	1997-08-31	Sour Pliva	9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
HRP950145A2 (en)	1995-03-27	1997-08-31	Sour Pliva	New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
HN1996000101A (en)	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS
CA2253338C (en) *	1996-05-07	2007-05-08	Abbott Laboratories	6-o-substituted erythromycins and method for making them
DE69739688D1 (en)	1996-07-05	2010-01-21	Biotica Tech Ltd	Hybrid polyketide synthase I gene
UA51730C2 (en) *	1996-09-04	2002-12-16	Ебботт Лабораторіз	6-0-substituted ketolides having antibacterial activity
DE69733369T2 (en) *	1996-09-04	2006-01-26	Abbott Laboratories, Abbott Park	6-o-substituted ketolides with antibacterial activity
HRP960497B1 (en) *	1996-10-28	2003-08-31	Pliva Pharm & Chem Works	9-n-ethenyl derivatives of 9(s)-erythromycylamine
US6407074B1 (en) *	1997-06-11	2002-06-18	Pfizer Inc	C-4″-substituted macrolide derivatives
HN1998000074A (en)	1997-06-11	1999-01-08	Pfizer Prod Inc	DERIVATIVES FROM MACROLIDES C-4 SUBSTITUTED
EP0895999A1 (en) *	1997-08-06	1999-02-10	Pfizer Products Inc.	C-4" substituted macrolide antibiotics
US6339063B1 (en)	1997-09-10	2002-01-15	Merck & Co., Inc.	9a-azalides as veterinary antimicrobial agents
EP1437359B1 (en)	1997-10-16	2006-12-20	GlaxoSmithKline istrazivacki centar Zagreb d.o.o.	Novel 3,6-Hemiketals from the Class of 9a-Azalides
ATE275151T1 (en) *	1998-03-03	2004-09-15	Pfizer Prod Inc	3,6-KETAL MACROLIDA ANTIBIOTIC
EE200100245A (en)	1998-11-03	2002-10-15	Pfizer Products Inc.	New macrolide antibiotics
EP1180110A1 (en)	1999-05-24	2002-02-20	Pfizer Products Inc.	13-methyl-erythromycin derivatives
EP1114826A3 (en)	1999-12-29	2001-10-31	Pfizer Products Inc.	Novel antibacterial and prokinetic macrolides
EP1122261A3 (en)	2000-01-31	2001-09-26	Pfizer Products Inc.	13 and 14-membered antibacterial macrolides
PT1167376E (en)	2000-06-30	2004-09-30	Pfizer Prod Inc	MACROLIDOS ANTIBIOTICS
JP4509553B2 (en)	2001-07-03	2010-07-21	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	C12-modified erythromycin macrolide and ketolide having antibacterial activity

1999
- 1999-10-18 EE EEP200100245A patent/EE200100245A/en unknown
- 1999-10-18 KR KR1020017005535A patent/KR20010083944A/en not_active Ceased
- 1999-10-18 OA OA1200100102A patent/OA11670A/en unknown
- 1999-10-18 PL PL99348114A patent/PL348114A1/en not_active Application Discontinuation
- 1999-10-18 IL IL14262899A patent/IL142628A0/en unknown
- 1999-10-18 CN CN99812941A patent/CN1376160A/en active Pending
- 1999-10-18 CA CA002349338A patent/CA2349338C/en not_active Expired - Fee Related
- 1999-10-18 HU HU0104192A patent/HUP0104192A3/en unknown
- 1999-10-18 CZ CZ20011512A patent/CZ20011512A3/en unknown
- 1999-10-18 BR BR9914998-2A patent/BR9914998A/en not_active IP Right Cessation
- 1999-10-18 ID IDW20010956D patent/ID28286A/en unknown
- 1999-10-18 TR TR2002/00435T patent/TR200200435T2/en unknown
- 1999-10-18 AP APAP/P/2001/002131A patent/AP2001002131A0/en unknown
- 1999-10-18 TR TR2002/00436T patent/TR200200436T2/en unknown
- 1999-10-18 JP JP2000579612A patent/JP4043191B2/en not_active Expired - Fee Related
- 1999-10-18 AU AU59952/99A patent/AU5995299A/en not_active Abandoned
- 1999-10-18 WO PCT/IB1999/001701 patent/WO2000026224A2/en not_active Application Discontinuation
- 1999-10-18 TR TR2001/01241T patent/TR200101241T2/en unknown
- 1999-10-18 EA EA200100396A patent/EA200100396A1/en unknown
- 1999-10-18 HR HR20010306A patent/HRP20010306A2/en not_active Application Discontinuation
- 1999-10-18 SK SK581-2001A patent/SK5812001A3/en unknown
- 1999-10-18 EP EP99971424A patent/EP1124837A2/en not_active Withdrawn
- 1999-10-18 TR TR2002/00434T patent/TR200200434T2/en unknown
- 1999-10-18 HK HK03101144.0A patent/HK1049010A1/en unknown
- 1999-10-29 SV SV1999000188A patent/SV1999000188A/en not_active Application Discontinuation
- 1999-10-29 PE PE1999001084A patent/PE20001289A1/en not_active Application Discontinuation
- 1999-10-29 UY UY25780A patent/UY25780A1/en unknown
- 1999-11-02 PA PA19998485101A patent/PA8485101A1/en unknown
- 1999-11-02 MA MA25832A patent/MA26703A1/en unknown
- 1999-11-02 TN TNTNSN99205A patent/TNSN99205A1/en unknown
- 1999-11-03 GT GT199900192A patent/GT199900192A/en unknown
- 1999-11-03 CO CO99069359A patent/CO5140110A1/en unknown
2001
- 2001-04-17 IS IS5919A patent/IS5919A/en unknown
- 2001-04-23 ZA ZA200103289A patent/ZA200103289B/en unknown
- 2001-05-02 NO NO20012155A patent/NO20012155L/en not_active Application Discontinuation
- 2001-05-29 BG BG105543A patent/BG105543A/en unknown
- 2001-10-01 US US09/969,486 patent/US20020040007A1/en not_active Abandoned
2002
- 2002-07-24 US US10/206,652 patent/US6835716B2/en not_active Expired - Fee Related
2004
- 2004-07-21 US US10/896,293 patent/US7071170B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SK5812001A3 (en)	2001-12-03
BR9914998A (en)	2001-07-10
JP2002528553A (en)	2002-09-03
PE20001289A1 (en)	2000-11-22
CZ20011512A3 (en)	2001-09-12
HUP0104192A3 (en)	2003-12-29
TR200200435T2 (en)	2002-07-22
PL348114A1 (en)	2002-05-06
CN1376160A (en)	2002-10-23
CA2349338A1 (en)	2000-05-11
AP2001002131A0 (en)	2001-06-30
TR200200434T2 (en)	2002-09-23
OA11670A (en)	2005-01-12
PA8485101A1 (en)	2002-08-26
WO2000026224A2 (en)	2000-05-11
US20030013665A1 (en)	2003-01-16
NO20012155L (en)	2001-07-02
CO5140110A1 (en)	2002-03-22
US20050004047A1 (en)	2005-01-06
HRP20010306A2 (en)	2002-06-30
TR200101241T2 (en)	2001-09-21
EE200100245A (en)	2002-10-15
IL142628A0 (en)	2002-03-10
ZA200103289B (en)	2002-08-28
UY25780A1 (en)	2001-08-27
EA200100396A1 (en)	2001-10-22
US7071170B2 (en)	2006-07-04
JP4043191B2 (en)	2008-02-06
HK1049010A1 (en)	2003-04-25
BG105543A (en)	2001-12-29
US20020040007A1 (en)	2002-04-04
AU5995299A (en)	2000-05-22
CA2349338C (en)	2005-12-06
SV1999000188A (en)	2000-10-16
US6835716B2 (en)	2004-12-28
KR20010083944A (en)	2001-09-03
NO20012155D0 (en)	2001-05-02
TR200200436T2 (en)	2002-06-21
TNSN99205A1 (en)	2005-11-10
HUP0104192A2 (en)	2002-02-28
EP1124837A2 (en)	2001-08-22
GT199900192A (en)	2001-04-26
WO2000026224A3 (en)	2000-11-16
ID28286A (en)	2001-05-10
MA26703A1 (en)	2004-12-20

Publication	Publication Date	Title
IS5528A (en)	2000-06-09	New macrolide
ATE322910T1 (en)	2006-04-15	NOVEL ANTIBIOTICS
DK0941998T3 (en)	2004-09-20	3,6-ketal macrolide antibiotics
EE200100245A (en)	2002-10-15	New macrolide antibiotics
DE60124594D1 (en)	2006-12-28	macrolide antibiotics
ATE256694T1 (en)	2004-01-15	KETOLIDE ANTIBIOTICS
ATE310742T1 (en)	2005-12-15	C-4ß-SUBSTITUTED MACROLIDE DERIVATIVES
DE69838651D1 (en)	2007-12-13	erythromycin
IS5251A (en)	1999-11-16	9-oxime erythromycin derivatives
PT1119430E (en)	2004-03-31	STRAWBERRY
DE69902762D1 (en)	2002-10-10	RISER-SPAN ARRANGEMENT
ID27775A (en)	2001-04-26	NOKATIASIN ANTIBIOTICS
DK1027362T3 (en)	2005-10-31	2-halo-6-O-substituted ketolide derivatives
PT1076660E (en)	2002-11-29	(4-BROMOPYRAZOL-3-YL) -BZZAZOLES
NO20016200L (en)	2002-02-12	Antibiotics
PT984975E (en)	2003-09-30	MULTICICULAR ERYTHROMYCIN DERIVATIVES
FI971952A0 (en)	1997-05-07	Antibiotic aemne
ID26522A (en)	2001-01-11	ANTIBIOTIC STEROID DOWN
BR1100453A (en)	2006-05-09	erythromycin derivatives
SE9902890D0 (en)	1999-08-12	Floor-related arrangement
UA3150S (en)	1999-11-12	COOKIES
UA3149S (en)	1999-11-12	COOKIES